Literature DB >> 28535966

Medical devices for cystic fibrosis care may be portable reservoirs of potential pathogens.

B Linnane1, L Collins2, N Bussmann2, N H O'Connell1, C P Dunne3.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28535966     DOI: 10.1016/j.jhin.2017.04.015

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


× No keyword cloud information.
  5 in total

1.  Longitudinal monitoring of sinonasal and oral bacterial reservoirs to prevent chronic lung infection in people with cystic fibrosis.

Authors:  Rebeca Passarelli Mantovani; Angela Sandri; Marzia Boaretti; Gloria Burlacchini; Veronica Li Vigni; Mattia Scarazzai; Paola Melotti; Caterina Signoretto; Maria M Lleo
Journal:  ERJ Open Res       Date:  2020-08-25

2.  A short-term evaluation of a prototype disposable Oscillating Positive Expiratory Pressure (OPEP) device in a cohort of children with cystic fibrosis.

Authors:  Kevin J O'Sullivan; Valerie Power; Barry Linnane; Deirdre McGrath; Magdalena Mulligan; Rebecca White; Leonard W O'Sullivan; Colum P Dunne
Journal:  BMC Pulm Med       Date:  2021-05-12       Impact factor: 3.317

3.  Assessment of the microbial load of airway clearance devices used by a cohort of children with cystic fibrosis.

Authors:  B Linnane; N H O'Connell; E Obande; S S Dunne; C Clancy; M G Kiernan; D McGrath; K J O'Sullivan; L O'Sullivan; C P Dunne
Journal:  Infect Prev Pract       Date:  2021-06-06

4.  An initial evaluation of the safety of a disposable oscillating positive expiratory pressure device in patients with chronic obstructive pulmonary disease: a sort-term pilot study.

Authors:  Kevin J O'Sullivan; Valerie Power; Barry Linnane; Deirdre McGrath; Hilda Fogarty; Martina Ryan; Rebecca White; Conor Noonan; Eithne Mulloy; Leonard W O'Sullivan; Colum P Dunne
Journal:  BMC Pulm Med       Date:  2021-10-19       Impact factor: 3.317

5.  Advances in the Microbiology of Stenotrophomonas maltophilia.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2021-05-26       Impact factor: 50.129

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.